Two weeks ago, a newly study indicated that a pair of widely used diabetes drugs – Merck’s Januvia and Bristol-Myers Squibb’s Byetta can double the risk of developing pancreatitis, which is an inflammation of the pancreas that is linked to cancer ...
[Published Pharmalot - Mar 15 2013]